Forekomsten var dog sjælden, og opfølgningstiden for placebo patienter var kortere end for patienter, der fik TNF- antagonistbehandling.
6 occurrence was rare, and the follow-up period of placebo patients was shorter than for patients receiving TNF-antagonist therapy.